Framingham News

City News

Posted on: April 26, 2021

COVID-19 Update, Monday, April 26

FOR IMMEDIATE RELEASE 04/26/2021

For further information, contact:
Kelly McFalls
kmcfalls@framinghamma.gov
Tel (508) 532-5437
M (774) 285-1315

*COVID-19 UPDATE*
Since Friday, April 23, 33 Residents have Tested Positive, and 36 More have Recovered from COVID-19; 
City Signs Contract to Relocate Project Beacon’s Drive-Through COVID-19 Testing Site; 
Weekly Food Resource Guide; 
Update on the Vaccine Equity Initiative in Framingham

  • Since Friday, April 23, 33 residents have tested positive, and 36 more have recovered from COVID-19: The number of people in the City who have tested positive for COVID-19 is 8,101. With 6,317 recovered and 243 fatalities, Framingham currently has 1,541 active cases. The Framingham Health Department contacts the people who were potentially exposed and the owners of the businesses or places of employment where the potential exposures occurred to inform and counsel them on next steps (contact tracing). In addition to the active cases, the Health Department is following 581 residents in quarantine. 

  • City signs contract to relocate Project Beacon’s Drive-through COVID-19 testing site: The current site at 484 Franklin Street is set to close Sunday, May 2. Project Beacon’s new drive-through testing site will be located at 123 Maple Street (Framingham State University’s Maple Street Commuter Lot) and is anticipated to open on Friday, May 7. Walk-through testing remains available at Saint Tarcisius Parish - 562 Waverly Street, Framingham, MA 01702. The walk-though Site is located indoors at the Father Maschi Parish Center, behind the parish. Walk-through testing hours are Mondays, Tuesdays, and Thursdays: 11 a.m. – 7 p.m., and Wednesdays and Fridays: 8 a.m.-4 p.m.
    • New Drive-through Location:  123 Maple Street (Maple Street Commuter Lot)
    • When: Starting Friday, May 7
    • Scheduling an appointment: Please register online at https://app.beacontesting.com/login to see available appointment slots. (NO WALK-INS)
    • Eligibility: Open to everyone; symptomatic and asymptomatic
    • Format: Drive-through only
    • Cost: FREE; no health insurance required 
    • Test Results: Results will be available within 1-3 (business) days after test administration
  • Weekly food resource guide: To better manage the food demand, Framingham's Emergency Food Line's coordinators have developed a weekly guide about residents' food availability. View this week's guide in English, Portuguese, and Spanish, here.
  • Update on the Vaccine Equity Initiative in Framingham: The City is one of 20 municipalities designated to be a Vaccine Equity Initiative member. Guided by the State's framework, the Equity Initiative includes people of color, immigrants and recent arrivals, homebound and disabled individuals, individuals living in low-income and congregate housing, and individuals with multiple and complex medical needs.

    Last week, clinics were held at the BRACE, Greater Framingham Community Church, Interfaith Terrace, Latino Health Insurance, Metrowest Worker Center, New Life Church, and Pelham Learning Center. Since Wednesday, March 24, 2,727 dose one, 232 dose two Moderna, and 289 *Johnson and Johnson (J&J) vaccinations have been administered under the Equity Initiative.

    The Framingham Health Department and Medical Reserve Corps have conducted 127 home visits for functionally disabled and homebound residents to administer vaccines. To request a home visit, please call the City's Public Health Nursing Office at 508-532-5667. Leave your name, phone number, and address, and someone will return your call within 36 hours.

    Those who received dose one of Moderna were invited to return for a second dose at the same community site to become fully vaccinated. The COVID Vaccine Team will continue to offer several clinics each week for the equity imitative at a variety of locations. Framingham's weekly equity vaccination data report provided by the State of Massachusetts can be found here.

    *As of today, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) lifted the recommended pause on the J&J COVID-19 vaccine. Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the FDA and CDC have determined that the recommended pause regarding the use of the J&J COVID-19 vaccine in the U.S. should be lifted, and use of the vaccine should resume. The City will announce future plans to offer the J&J vaccine through the Vaccine Equity Initiative.

  • COVID-19 in Framingham: Information on COVID-19 in Framingham can be found here. To receive information from the City on a mobile device, text "Join FraminghamMA" to 30890. Residents also can find updates on Facebook and Twitter - @Framingham_MA. For questions regarding COVID-19 in Framingham, please call the City's informational line at (508) 532-5411, Mon-Fri., 8:30 a.m.- 3:30 p.m. If there is an urgent update, the City will employ the "Alert Framingham" phone messaging system, otherwise known as Rave. To sign up for the City's Rave system, please go here: https://www.smart911.com/

                                                                                                          ###

Additional Info...
Facebook Twitter Email